£2 million for MS research in Edinburgh

Published date: 28 Apr 2015 at 1:23PM

We’ve committed to investing over £2 million in the Edinburgh Centre for MS Research, so that they can continue their world-class research for a further 5 years.

We set up the Edinburgh Centre (formerly known as the Edinburgh Centre for Translational Research) in 2007 with the generous support of the Volant Trust. The overall aim was to find effective treatments for people with MS.

How did we decide?

The co-directors of the Edinburgh Centre, Professors Siddharthan Chandran and Charles ffrench-Constant, presented their future plans to the management board, which is made up of independent MS research scientists and people affected by MS from the MS Society Research Network. After the meeting, the board strongly recommended that we renew funding so that they can continue their exciting research for another 5 years.

Stem cell focus

Researchers at the centre will use this investment to focus on understanding the causes and mechanisms behind progressive MS, along with testing news ways to stop or reverse progression. Crucially, they’ll be using stem cells as a model for studying MS in the lab, taking a closer look at the underlying biology of MS in neurons and the surrounding environment.

Supporting the MS scientists of the future

Michelle Mitchell, Chief Executive of the MS Society in the UK, said: “We know that people with MS desperately want treatments that can slow, stop or reverse the effects of MS progression – and the world-class researchers at the Edinburgh Centre could be pivotal in paving the way for how the condition is treated in the future.

“Aside from the cutting-edge research being carried out there, it’s also a place where highly promising young scientists are being supported to embark on a career in the field of MS, ensuring the best scientific minds are focussed on finding answers for people with the condition for years to come” 

We need your support

Researchers at the Edinburgh Centre are working hard to find effective treatments that slow or stop MS progression, which is our number one research priority. Help them to make that happen by donating to research.

Read more

Project summary: the Edinburgh Centre for MS Research

Information about our Research Network

Two potential myelin repair treatments identified

Optic neuritis trials: encouraging results announced

MS-SMART trial for secondary progressive MS underway

Page tagged with:
Page last updated: 29 Jun 2015
World-class researchers at the Edinburgh Centre could be pivotal in paving the way for how the condition is treated in the future.
Michelle Mitchell, Chief Executive of the MS Society
Read more

What's new?